To: Nero who wrote (1084 ) 5/25/1998 11:26:00 PM From: Ron Dior Read Replies (1) | Respond to of 2135
Nero, ENMD has a fair market value of $12 based on price performance of the stock. Over the last 3 years this stock has proven that $12 is fair value. The market is comfortable with this price and I would be at ease buying at that level. I certainly feel that my money could earn more elsewhere, but if I had to buy ENMD for a long term prospect, I would feel somewhat safe at $12. Now concerning the latest spike in the stock price. Had the price spiked to $85 because the company had found a cure for cancer, or DEFINITELY made positive steps that would EVENTUALY lead to a cure for certain. Then the fair value would most definitely had changed for ENMD. The fact of the matter is, that in all of the research I have done on this company, I cannot find any proof that this news was anything beyond what was already known. The bottom line is that they are no further along than MANY other companies who are racing to cure cancer. What was released as ground breaking news was inaccurate! This was old news, not a cure for cancer. All of these companies may be closer than ever to a cure, but no one knows how close they actually are. It could be 50 more years before a cure is found and to release something to give people false hope is in my opinion irresponsible! The odds of cancer being cured any time soon are very high and the odds of it being ENMD are astronomical. Remember one thing when you make statements like " I'd rather put my money on Judah Folkman's research", if you took the same amount of money that you have invested in Judah Folkman's research and went to Vegas, put it all on black , at least you would have a 50% chance of winning. The odds of ENMD curing cancer are a little worse than 50/50 IMO! Ron Dior